To ask the Secretary of State for Health if she will make a statement on the Government's plan to implement the National Institute for Health and Clinical Excellence's guidelines on dementia. (109905)

It is for health and social care to implement the National Institute for Health and Clinical Excellence's guidelines on dementia.

The Department is committed to promoting improvements in services for people with dementia and their carers. The guidelines will be very important in supporting improved standards of health and social care for people with dementia and their families. We will be taking a close interest in the development of these services.

To ask the Secretary of State for Health what drug treatments are recommended by the National Institute for Health and Clinical Excellence for the treatment of dementia with Lewy body disease. (109906)

On 22 November 2006, the National Institute for Health and Clinical Excellence and the Social Care Institute for Excellence (SCIE) issued a joint clinical guideline on the treatment and care of people with dementia. This made a number of recommendations on pharmacological and non-pharmacological treatments for symptoms affecting mood and behaviour. It recommends that donepezil, galantamine and rivastigmine may be offered to a small number of patients with dementia with Lewy bodies if these symptoms are causing severe distress.